Gene Therapy Slows Huntington’s Disease Progression for First Time
October 1, 2025
In a breakthrough clinical trial, a single injection of a gene therapy slowed the progression of Huntington’s disease by as much as 75%.
In a breakthrough clinical trial, a single injection of a gene therapy slowed the progression of Huntington’s disease by as much as 75%.
We address some of the common misconceptions surrounding research and clinical trials and provide you with the facts!
Researchers found that those who consumed the highest amounts of sugar substitutes experienced a 62% faster decline in cognitive skills.
Researchers found that those who consumed the highest amounts of sugar substitutes experienced a 62% faster decline in cognitive skills.
Curcumin, turmeric’s active component found to help with wait loss for those with diabetes, potentially reducing the need for costly medications.
Clinical trial showed zero new HIV infections with those who took Yeytuo, the twice yearly administered injection recently approved for marketing.
We are partnering with the T1DRA study and the University of Bristol to offer you the opportunity to learn more about your health.
Engaging in regular aerobic exercise, such as running, cycling, or brisk walking, can reduce the risk of dementia by up to 76%.
Findings suggest that combining a cholesterol-lowering drug, with an experimental PIN1 inhibitor was effective at slowing tumor growth.
Eating at least five servings of dark chocolate a week may lower your risk of type 2 diabetes by 21% say findings from a Harvard study of 192,000 adults.
Findings highlight the important role of gut bacteria in boosting the protective effects of dietary fiber against bowel cancer.
A study found that those who drank green tea had 35% fewer white matter lesions, which are associated with cognitive impairment and dementia.
Could participating from home shift the burdens away from patients? We spoke to over 900 of our members to hear their preferences.
Mindfulness-based stress reduction program shown to be as effective as the antidepressant escitalopram in easing anxiety symptoms.
Karen participated in a webinar to share her experiences so that patients’ preferences and barriers for participating in clinical trials can be heard.
Through signing up as a member, we will keep you up to date with the latest research news, member stories and community updates through our quarterly newsletters. You can also follow us on Facebook and Twitter.
We always value hearing from our members. We send out surveys and questionnaires and conduct interviews so that you can share your input on a range of topics. If there is something in particular you wish to share, feel free to email us on info@britishresearchpanel.co.uk.
As a member, we will email you with surveys and questionnaires so that you have the opportunity to share your input on a range of topics.
This page is updated ahead of our quarterly newsletters. You can also stay up to date with us on Facebook and Twitter.
Yes, we encourage you to share these resources and help raise awareness of clinical research and our member stories.